Cite
Genetic polymorphisms of SCNA9 as predictive markers of oxaliplatin-induced neuropathy
MLA
Enrique Casado, et al. Genetic Polymorphisms of SCNA9 as Predictive Markers of Oxaliplatin-Induced Neuropathy. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d1d6b3de8384e59051203be7798d35f&authtype=sso&custid=ns315887. Accessed 28 Jan. 2025.
APA
Enrique Casado, Francisco Zambrana Tevar, Cesar gomez Lopez, Lara Sanchez, Maria J. Merino, Cristina Rodríguez-Antona, María Sereno, Miriam Lopez Gomez, Ambrosio Miralles, & Gerardo Gutiérrez-Gutiérrez. (n.d.). Genetic polymorphisms of SCNA9 as predictive markers of oxaliplatin-induced neuropathy.
Chicago
Enrique Casado, Francisco Zambrana Tevar, Cesar gomez Lopez, Lara Sanchez, Maria J. Merino, Cristina Rodríguez-Antona, María Sereno, Miriam Lopez Gomez, Ambrosio Miralles, and Gerardo Gutiérrez-Gutiérrez. 2025. “Genetic Polymorphisms of SCNA9 as Predictive Markers of Oxaliplatin-Induced Neuropathy.” Accessed January 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d1d6b3de8384e59051203be7798d35f&authtype=sso&custid=ns315887.